| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |